JPMorgan Chase & Co’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $119M | Buy |
3,260,868
+2,951,397
| +954% | +$107M | 0.01% | 798 |
|
|
2025
Q1 | $11.2M | Buy |
309,471
+103,684
| +50% | +$3.75M | ﹤0.01% | 2100 |
|
|
2024
Q4 | $8.66M | Sell |
205,787
-7,423
| -3% | -$312K | ﹤0.01% | 2351 |
|
|
2024
Q3 | $11.8M | Sell |
213,210
-7,815
| -4% | -$434K | ﹤0.01% | 2056 |
|
|
2024
Q2 | $9.08M | Sell |
221,025
-31,135
| -12% | -$1.28M | ﹤0.01% | 2168 |
|
|
2024
Q1 | $11.8M | Sell |
252,160
-25,782
| -9% | -$1.2M | ﹤0.01% | 2025 |
|
|
2023
Q4 | $13.3M | Buy |
277,942
+2,351
| +0.9% | +$112K | ﹤0.01% | 1902 |
|
|
2023
Q3 | $9.82M | Sell |
275,591
-37,554
| -12% | -$1.34M | ﹤0.01% | 1978 |
|
|
2023
Q2 | $14.4M | Buy |
313,145
+24,077
| +8% | +$1.11M | ﹤0.01% | 1779 |
|
|
2023
Q1 | $11.6M | Sell |
289,068
-6,087
| -2% | -$244K | ﹤0.01% | 1892 |
|
|
2022
Q4 | $13.7M | Sell |
295,155
-17,616
| -6% | -$816K | ﹤0.01% | 1698 |
|
|
2022
Q3 | $13M | Buy |
312,771
+17,814
| +6% | +$738K | ﹤0.01% | 1702 |
|
|
2022
Q2 | $17.6M | Sell |
294,957
-6,186
| -2% | -$369K | ﹤0.01% | 1515 |
|
|
2022
Q1 | $21.9M | Sell |
301,143
-20,411
| -6% | -$1.48M | ﹤0.01% | 1487 |
|
|
2021
Q4 | $27M | Buy |
321,554
+11,303
| +4% | +$950K | ﹤0.01% | 1378 |
|
|
2021
Q3 | $28M | Sell |
310,251
-40,668
| -12% | -$3.67M | ﹤0.01% | 1348 |
|
|
2021
Q2 | $33.5M | Buy |
350,919
+44,440
| +15% | +$4.24M | ﹤0.01% | 1285 |
|
|
2021
Q1 | $34.9M | Buy |
306,479
+75,049
| +32% | +$8.55M | ﹤0.01% | 1235 |
|
|
2020
Q4 | $32M | Buy |
231,430
+45,456
| +24% | +$6.29M | ﹤0.01% | 1169 |
|
|
2020
Q3 | $15.8M | Buy |
185,974
+36,867
| +25% | +$3.14M | ﹤0.01% | 1467 |
|
|
2020
Q2 | $11.7M | Buy |
149,107
+37,397
| +33% | +$2.93M | ﹤0.01% | 1595 |
|
|
2020
Q1 | $4.96M | Buy |
111,710
+55,186
| +98% | +$2.45M | ﹤0.01% | 2010 |
|
|
2019
Q4 | $2.41M | Buy |
56,524
+35,368
| +167% | +$1.51M | ﹤0.01% | 2592 |
|
|
2019
Q3 | $906K | Buy |
21,156
+3,107
| +17% | +$133K | ﹤0.01% | 3113 |
|
|
2019
Q2 | $1.12M | Sell |
18,049
-1,227
| -6% | -$76.1K | ﹤0.01% | 3002 |
|
|
2019
Q1 | $1.34M | Buy |
19,276
+5,645
| +41% | +$392K | ﹤0.01% | 2874 |
|
|
2018
Q4 | $593K | Buy |
13,631
+594
| +5% | +$25.8K | ﹤0.01% | 3303 |
|
|
2018
Q3 | $995K | Sell |
13,037
-3,688
| -22% | -$281K | ﹤0.01% | 3176 |
|
|
2018
Q2 | $1.29M | Sell |
16,725
-4,372
| -21% | -$336K | ﹤0.01% | 3017 |
|
|
2018
Q1 | $1.08M | Sell |
21,097
-570
| -3% | -$29.1K | ﹤0.01% | 3051 |
|
|
2017
Q4 | $1.01M | Sell |
21,667
-169,537
| -89% | -$7.86M | ﹤0.01% | 3059 |
|
|
2017
Q3 | $10.3M | Sell |
191,204
-3,536
| -2% | -$191K | ﹤0.01% | 1714 |
|
|
2017
Q2 | $12.1M | Sell |
194,740
-48,866
| -20% | -$3.03M | ﹤0.01% | 1609 |
|
|
2017
Q1 | $16.5M | Sell |
243,606
-12,039
| -5% | -$816K | ﹤0.01% | 1401 |
|
|
2016
Q4 | $18M | Sell |
255,645
-25,904
| -9% | -$1.82M | ﹤0.01% | 1344 |
|
|
2016
Q3 | $20M | Buy |
281,549
+18,212
| +7% | +$1.29M | ﹤0.01% | 1232 |
|
|
2016
Q2 | $12.9M | Buy |
263,337
+5,806
| +2% | +$284K | ﹤0.01% | 1512 |
|
|
2016
Q1 | $16.3M | Buy |
257,531
+14,863
| +6% | +$941K | ﹤0.01% | 1326 |
|
|
2015
Q4 | $27.2M | Buy |
242,668
+60,442
| +33% | +$6.78M | 0.01% | 1011 |
|
|
2015
Q3 | $17.6M | Buy |
182,226
+46,328
| +34% | +$4.46M | ﹤0.01% | 1230 |
|
|
2015
Q2 | $13.9M | Sell |
135,898
-70,532
| -34% | -$7.22M | ﹤0.01% | 1482 |
|
|
2015
Q1 | $12.8M | Buy |
206,430
+5,137
| +3% | +$319K | ﹤0.01% | 1577 |
|
|
2014
Q4 | $8.83M | Buy |
201,293
+5,793
| +3% | +$254K | ﹤0.01% | 1760 |
|
|
2014
Q3 | $11.1M | Sell |
195,500
-2,575
| -1% | -$146K | ﹤0.01% | 1604 |
|
|
2014
Q2 | $8.89M | Buy |
198,075
+16,515
| +9% | +$741K | ﹤0.01% | 1764 |
|
|
2014
Q1 | $8.88M | Buy |
+181,560
| New | +$8.88M | ﹤0.01% | 1750 |
|